Literature DB >> 24728240

Premalignant and malignant lesions in endometrial polyps in patients undergoing hysteroscopic polypectomy.

Marco Antonio Lenci1, Vanessa Alessandra Lui do Nascimento2, Ana Beatriz Grandini3, Walid Makin Fahmy3, Daniella de Batista Depes3, Fausto Farah Baracat3, Reginaldo Guedes Coelho Lopes3.   

Abstract

OBJECTIVE: To evaluate the incidence of premalignant lesions and cancer in endometrial polyps, in patients undergoing hysteroscopic polypectomy.
METHODS: The results of 1,020 pathological examinations of patients submitted to hysteroscopic polypectomy were analyzed, as well as their diagnostic and surgical hysteroscopy findings. As to their menstrual status, 295 (28.9%) patients were in menacme. Of the total, 193 (65.4%) presented abnormal uterine bleeding, and 102 (34.6%) were asymptomatic with altered endometrial echo on transvaginal ultrasound. Out of 725 (71.1%) postmenopausal patients, 171 (23.6%) were symptomatic (abnormal uterine bleeding), and 554 (76.4%) were asymptomatic with endometrial echo >5.0mm.
RESULTS: Twenty-one (2.0%) patients presented premalignant lesions in the polyps, 13 had simple glandular hyperplasia, of which 5 had no atypia, and eight presented atypia. Eight polyps presented focal area of complex hyperplasia: 4 with atypia and 4 without lesions. Cancer was diagnosed in 5 (0.5%) polyps. Of the 21 polyps that harbored premalignant lesions, 12 were interpreted as benign in diagnostic and surgical hysteroscopy. Of the polyps with cancer, 4 were also histeroscopically interpreted as normal.
CONCLUSION: Symptomatic polyps in menacme and in all postmenopausal women should be resected and submitted to histopathological examination, since they may have a benign aspect, even when harboring areas of cellular atypia or cancer.

Entities:  

Mesh:

Year:  2014        PMID: 24728240      PMCID: PMC4898233          DOI: 10.1590/s1679-45082014ao2764

Source DB:  PubMed          Journal:  Einstein (Sao Paulo)        ISSN: 1679-4508


  27 in total

1.  Endometrial polyps: symptomatology, menopausal status and malignancy.

Authors:  Abraham Golan; Bina Cohen-Sahar; Ran Keidar; Alexander Condrea; Shimon Ginath; Ron Sagiv
Journal:  Gynecol Obstet Invest       Date:  2010-03-20       Impact factor: 2.031

2.  Sequential relationship between endometrial polyps and carcinoma of the endometrium.

Authors:  C S Armenia
Journal:  Obstet Gynecol       Date:  1967-10       Impact factor: 7.661

3.  Occurrence of malignancy in endometrial polyps during postmenopause.

Authors:  B Mossa; F Torcia; F Avenoso; S Tucci; R Marziani
Journal:  Eur J Gynaecol Oncol       Date:  2010       Impact factor: 0.196

Review 4.  Treatment of endometrial polyps: a systematic review.

Authors:  Marit Lieng; Olav Istre; Erik Qvigstad
Journal:  Acta Obstet Gynecol Scand       Date:  2010-08       Impact factor: 3.636

5.  Estrogen and progesterone receptor expression in endometrial polyps.

Authors:  K Mittal; L Schwartz; S Goswami; R Demopoulos
Journal:  Int J Gynecol Pathol       Date:  1996-10       Impact factor: 2.762

6.  Endometrial polyps. A clinical study of 245 cases.

Authors:  T Reslová; J Tosner; M Resl; R Kugler; I Vávrová
Journal:  Arch Gynecol Obstet       Date:  1999       Impact factor: 2.344

7.  Endometrial cancer in polyps: a clinical study of 27 cases.

Authors:  C Martín-Ondarza; A Gil-Moreno; L Torres-Cuesta; A García; F Eyzaguirre; B Díaz-Feijoo; J Xercavins
Journal:  Eur J Gynaecol Oncol       Date:  2005       Impact factor: 0.196

8.  Analysis of estrogen- and progesterone-receptor expression in endometrial polyps.

Authors:  Reginaldo Guedes C Lopes; Edmund Chada Baracat; Luiz Cavalcanti de Albuquerque Neto; José Francisco Dória Ramos; Salete Yatabe; Daniela Baptista Depesr; Umberto Gazi Lippi
Journal:  J Minim Invasive Gynecol       Date:  2007 May-Jun       Impact factor: 4.137

9.  How often are endometrial polyps malignant?

Authors:  Asher Shushan; Ariel Revel; Nathan Rojansky
Journal:  Gynecol Obstet Invest       Date:  2004-08-12       Impact factor: 2.031

10.  Malignancy in endometrial polyps: a 12-year experience.

Authors:  Gabriela Baiocchi; Natalina Manci; Michela Pazzaglia; Laura Giannone; Liliana Burnelli; Ettore Giannone; Daniela Fratini; Gian Carlo Di Renzo
Journal:  Am J Obstet Gynecol       Date:  2009-07-26       Impact factor: 8.661

View more
  2 in total

1.  Concomitant p53 and PTEN immunoexpression to predict the risk of malignancy in endometrial polyps.

Authors:  Féres Abrão; Waldir Pereira Modotti; Daniel Spadoto-Dias; Flávia Neves Bueloni-Dias; Nilton José Leite; Gustavo Filipov Peres; Leonardo Vieira Elias; Maria Aparecida Custódio Domingues; Rogério Dias
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

2.  Noninvasive Predictor for Premalignant and Cancerous Lesions in Endometrial Polyps Diagnosed by Ultrasound.

Authors:  Jianying Xu; Xuan Rao; Weiguo Lu; Xing Xie; Xinyu Wang; Xiao Li
Journal:  Front Oncol       Date:  2022-01-27       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.